Clinical Trial Update: Efficacy of Diacerein Supplementation on Interleukin-1β, Hs-CRP, TNF-α Levels and Glycemic Control in Uncontrolled Type 2 Diabetes Mellitus Patients at Dr. Mohammad Hoesin General Hospital Palembang [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 clinical trial assessed the effects of diacerein supplementation on inflammatory markers (IL-1β, hs-CRP, TNF-α) and glycemic control in ad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Diacerein (Diacerein)

Snippet

Sponsor: Universitas Sriwijaya | Conditions: Uncontrolled Diabetes, Diabetes Mellitus Type 2 | Phase 2, Phase 3 | Status: COMPLETED